Email This Content
Send an email to a colleague about this document. Non-subscribers may purchase the article.© Copyright 2010 WINDHOVER INFORMATION INC., All Rights Reserved
Windhover Information Inc. - Health Care Business Intelligence
Delivering essential analysis and insights to top health care executives, investment professionals, and industry consultants
By Tom Salemi, IN VIVO 4/1/2009
IN VIVO -- The financial world may be in crisis, but top-tier medical device companies can still raise capital. But at what price? Four medical device execs answer those questions and many more.
For $125, purchase this 5492-word article as a PDF, and receive immediate delivery via email. View a complete sample article.
Questions? Call Toll Free (800) 332-2181 or (908) 547-2159.
100% Satisfaction Guarantee
If you are already a subscriber, please log in for complete access. 
Questions? Call Toll Free (800) 332-2181 or (908) 547-2159.
Click an article title to see a free preview.
Device Investing in Tough Times: The Venture View, IN VIVO 7/1/2009
A New Chapter for Device VCs, Medtech Insight 4/1/2009
Device VCs not Immune to Crisis, Start-Up 10/1/2008
Acclarent, By a Nose, The IN VIVO Blog 6/1/2008
superDimension: Navigating Interventional Pulmonology, IN VIVO 11/1/2007
Acclarent: Can Balloons Open Sinuses and the ENT Device Market?, IN VIVO 1/1/2006
